CLARIFLU

This brand name is authorized in Hong Kong

Active ingredients

The drug CLARIFLU contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 7AJO3BO7QN - LORATADINE
 

Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage.

 
Read more about Loratadine
2
UNII 362O9ITL9D - ACETAMINOPHEN
 

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.

 
Read more about Paracetamol
3
UNII Y9DL7QPE6B - PSEUDOEPHEDRINE SULFATE
 

Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion.

 
Read more about Pseudoephedrine

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
HK Department of Health Drug Office 47205

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.